Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jun 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well a telehealth program can help patients with moderate to severe chronic graft-versus-host disease (cGVHD), a condition that can occur after a stem cell or bone marrow transplant. The program focuses on providing palliative care, which means it aims to improve the quality of life for patients by managing symptoms and providing support, rather than trying to cure the disease. The study is currently recruiting participants who are adults over 18 years old, speak and understand English, and have been assessed by their healthcare provider as having moderate to severe cGVHD.

If you decide to participate, you'll be involved in a program that uses technology to connect with healthcare providers from the comfort of your home. This is a proof-of-concept study, meaning it's an early stage trial to see if the approach works well. Participants will need to be able to understand and respond to questions in English, as the study materials are in that language. It's important to note that individuals with serious psychiatric or cognitive conditions that could affect their ability to participate or provide consent, or those who are currently receiving palliative care, will not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) Adult patients (\>18 years)
• • 2) Have moderate to severe cGVHD based on their oncology clinician assessment as documented in the electronic health record.
• • 3) Ability to comprehend and speak English, and to read and respond to questions in English
• • Please note that this is a proof-of-concept study, and we only include patients who comprehend, read, and respond to questions in English since the study instruments are all available in English. However, as we have done in prior studies, we will expand the population in a future efficacy trial.
• Exclusion Criteria:
• • 1) Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believe prohibits informed consent or compliance with study procedures
• • 2) Patients who have already consulted or are currently consulting palliative care